Effect of Oral Bisphosphonate Drug Holiday on Mortality Following Hip Fracture Article Swipe
Miriam T Y Leung
,
Justin P. Turner
,
Clara Marquina
,
Jenni Ilomäki
,
Tim Tran
,
J. Simon Bell
·
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.1210/clinem/dgae272
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.1210/clinem/dgae272
Context Current clinical guidelines recommend a drug holiday after extended use of oral bisphosphonates. However, no studies have investigated the effect of drug holidays before hip fractures on postfracture mortality. Objective This work aimed to investigate the effect of a drug holiday on postfracture mortality in patients with extended use of oral bisphosphonates. Methods This retrospective, population-based cohort study took place among all patients with hip fractures in Victoria, Australia, from 2014 to 2018. Patients were adherent to oral alendronate or risedronate for 5 years or more prior to hip fracture. Group-based trajectory modeling categorized patients into different bisphosphonate usage after 5-year good adherence. The main outcome measure was postfracture mortality. Results We identified 365 patients with good adherence (medication possession ratio ≥80%) to oral alendronate/risedronate for 5 years or more. Most patients (69%) continued to use oral bisphosphonates until admission for hip fracture; 17% had discontinued for 1 year and 14% had discontinued for 2 years. Postfracture mortality was higher in patients who had discontinued risedronate for 1 year (hazard ratio [HR] 2.37; 95% CI, 1.24-4.53) and 2 years (HR 3.08; 95% CI, 1.48-6.41) prior to hip fracture. No increase or decrease in postfracture mortality was observed in patients who had discontinued alendronate for 1 year (HR 0.59; 95% CI, 0.29-1.18) or 2 years (HR 1.05; 95% CI, 0.57-1.93) prior to hip fracture. Conclusion Postfracture mortality is higher in people who discontinue risedronate, but not alendronate, for 1 or 2 years after being adherent to treatment for at least 5 years. The type of bisphosphonate may be a factor to consider when planning drug holidays.
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1210/clinem/dgae272
- OA Status
- hybrid
- Cited By
- 6
- References
- 43
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4394868978
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4394868978Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1210/clinem/dgae272Digital Object Identifier
- Title
-
Effect of Oral Bisphosphonate Drug Holiday on Mortality Following Hip FractureWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2024Year of publication
- Publication date
-
2024-04-17Full publication date if available
- Authors
-
Miriam T Y Leung, Justin P. Turner, Clara Marquina, Jenni Ilomäki, Tim Tran, J. Simon BellList of authors in order
- Landing page
-
https://doi.org/10.1210/clinem/dgae272Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
hybridOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.1210/clinem/dgae272Direct OA link when available
- Concepts
-
Hip fracture, Bisphosphonate, Medicine, Drug, Dentistry, Internal medicine, Osteoporosis, PharmacologyTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
6Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 3, 2024: 3Per-year citation counts (last 5 years)
- References (count)
-
43Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4394868978 |
|---|---|
| doi | https://doi.org/10.1210/clinem/dgae272 |
| ids.doi | https://doi.org/10.1210/clinem/dgae272 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/38630464 |
| ids.openalex | https://openalex.org/W4394868978 |
| fwci | 7.4918107 |
| mesh[0].qualifier_ui | |
| mesh[0].descriptor_ui | D006801 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | |
| mesh[0].descriptor_name | Humans |
| mesh[1].qualifier_ui | Q000401 |
| mesh[1].descriptor_ui | D006620 |
| mesh[1].is_major_topic | True |
| mesh[1].qualifier_name | mortality |
| mesh[1].descriptor_name | Hip Fractures |
| mesh[2].qualifier_ui | |
| mesh[2].descriptor_ui | D005260 |
| mesh[2].is_major_topic | False |
| mesh[2].qualifier_name | |
| mesh[2].descriptor_name | Female |
| mesh[3].qualifier_ui | |
| mesh[3].descriptor_ui | D008297 |
| mesh[3].is_major_topic | False |
| mesh[3].qualifier_name | |
| mesh[3].descriptor_name | Male |
| mesh[4].qualifier_ui | |
| mesh[4].descriptor_ui | D012189 |
| mesh[4].is_major_topic | False |
| mesh[4].qualifier_name | |
| mesh[4].descriptor_name | Retrospective Studies |
| mesh[5].qualifier_ui | |
| mesh[5].descriptor_ui | D000368 |
| mesh[5].is_major_topic | False |
| mesh[5].qualifier_name | |
| mesh[5].descriptor_name | Aged |
| mesh[6].qualifier_ui | Q000008 |
| mesh[6].descriptor_ui | D050071 |
| mesh[6].is_major_topic | True |
| mesh[6].qualifier_name | administration & dosage |
| mesh[6].descriptor_name | Bone Density Conservation Agents |
| mesh[7].qualifier_ui | Q000627 |
| mesh[7].descriptor_ui | D050071 |
| mesh[7].is_major_topic | True |
| mesh[7].qualifier_name | therapeutic use |
| mesh[7].descriptor_name | Bone Density Conservation Agents |
| mesh[8].qualifier_ui | |
| mesh[8].descriptor_ui | D000369 |
| mesh[8].is_major_topic | False |
| mesh[8].qualifier_name | |
| mesh[8].descriptor_name | Aged, 80 and over |
| mesh[9].qualifier_ui | |
| mesh[9].descriptor_ui | D000284 |
| mesh[9].is_major_topic | False |
| mesh[9].qualifier_name | |
| mesh[9].descriptor_name | Administration, Oral |
| mesh[10].qualifier_ui | Q000008 |
| mesh[10].descriptor_ui | D004164 |
| mesh[10].is_major_topic | True |
| mesh[10].qualifier_name | administration & dosage |
| mesh[10].descriptor_name | Diphosphonates |
| mesh[11].qualifier_ui | Q000627 |
| mesh[11].descriptor_ui | D004164 |
| mesh[11].is_major_topic | True |
| mesh[11].qualifier_name | therapeutic use |
| mesh[11].descriptor_name | Diphosphonates |
| mesh[12].qualifier_ui | Q000008 |
| mesh[12].descriptor_ui | D019386 |
| mesh[12].is_major_topic | True |
| mesh[12].qualifier_name | administration & dosage |
| mesh[12].descriptor_name | Alendronate |
| mesh[13].qualifier_ui | Q000627 |
| mesh[13].descriptor_ui | D019386 |
| mesh[13].is_major_topic | True |
| mesh[13].qualifier_name | therapeutic use |
| mesh[13].descriptor_name | Alendronate |
| mesh[14].qualifier_ui | Q000008 |
| mesh[14].descriptor_ui | D000068296 |
| mesh[14].is_major_topic | True |
| mesh[14].qualifier_name | administration & dosage |
| mesh[14].descriptor_name | Risedronic Acid |
| mesh[15].qualifier_ui | Q000706 |
| mesh[15].descriptor_ui | D055118 |
| mesh[15].is_major_topic | False |
| mesh[15].qualifier_name | statistics & numerical data |
| mesh[15].descriptor_name | Medication Adherence |
| mesh[16].qualifier_ui | Q000453 |
| mesh[16].descriptor_ui | D014739 |
| mesh[16].is_major_topic | False |
| mesh[16].qualifier_name | epidemiology |
| mesh[16].descriptor_name | Victoria |
| mesh[17].qualifier_ui | |
| mesh[17].descriptor_ui | D008875 |
| mesh[17].is_major_topic | False |
| mesh[17].qualifier_name | |
| mesh[17].descriptor_name | Middle Aged |
| mesh[18].qualifier_ui | |
| mesh[18].descriptor_ui | D000097042 |
| mesh[18].is_major_topic | False |
| mesh[18].qualifier_name | |
| mesh[18].descriptor_name | Treatment Interruption |
| mesh[19].qualifier_ui | |
| mesh[19].descriptor_ui | D006801 |
| mesh[19].is_major_topic | False |
| mesh[19].qualifier_name | |
| mesh[19].descriptor_name | Humans |
| mesh[20].qualifier_ui | Q000401 |
| mesh[20].descriptor_ui | D006620 |
| mesh[20].is_major_topic | True |
| mesh[20].qualifier_name | mortality |
| mesh[20].descriptor_name | Hip Fractures |
| mesh[21].qualifier_ui | |
| mesh[21].descriptor_ui | D005260 |
| mesh[21].is_major_topic | False |
| mesh[21].qualifier_name | |
| mesh[21].descriptor_name | Female |
| mesh[22].qualifier_ui | |
| mesh[22].descriptor_ui | D008297 |
| mesh[22].is_major_topic | False |
| mesh[22].qualifier_name | |
| mesh[22].descriptor_name | Male |
| mesh[23].qualifier_ui | |
| mesh[23].descriptor_ui | D012189 |
| mesh[23].is_major_topic | False |
| mesh[23].qualifier_name | |
| mesh[23].descriptor_name | Retrospective Studies |
| mesh[24].qualifier_ui | |
| mesh[24].descriptor_ui | D000368 |
| mesh[24].is_major_topic | False |
| mesh[24].qualifier_name | |
| mesh[24].descriptor_name | Aged |
| mesh[25].qualifier_ui | Q000008 |
| mesh[25].descriptor_ui | D050071 |
| mesh[25].is_major_topic | True |
| mesh[25].qualifier_name | administration & dosage |
| mesh[25].descriptor_name | Bone Density Conservation Agents |
| mesh[26].qualifier_ui | Q000627 |
| mesh[26].descriptor_ui | D050071 |
| mesh[26].is_major_topic | True |
| mesh[26].qualifier_name | therapeutic use |
| mesh[26].descriptor_name | Bone Density Conservation Agents |
| mesh[27].qualifier_ui | |
| mesh[27].descriptor_ui | D000369 |
| mesh[27].is_major_topic | False |
| mesh[27].qualifier_name | |
| mesh[27].descriptor_name | Aged, 80 and over |
| mesh[28].qualifier_ui | |
| mesh[28].descriptor_ui | D000284 |
| mesh[28].is_major_topic | False |
| mesh[28].qualifier_name | |
| mesh[28].descriptor_name | Administration, Oral |
| mesh[29].qualifier_ui | Q000008 |
| mesh[29].descriptor_ui | D004164 |
| mesh[29].is_major_topic | True |
| mesh[29].qualifier_name | administration & dosage |
| mesh[29].descriptor_name | Diphosphonates |
| mesh[30].qualifier_ui | Q000627 |
| mesh[30].descriptor_ui | D004164 |
| mesh[30].is_major_topic | True |
| mesh[30].qualifier_name | therapeutic use |
| mesh[30].descriptor_name | Diphosphonates |
| mesh[31].qualifier_ui | Q000008 |
| mesh[31].descriptor_ui | D019386 |
| mesh[31].is_major_topic | True |
| mesh[31].qualifier_name | administration & dosage |
| mesh[31].descriptor_name | Alendronate |
| mesh[32].qualifier_ui | Q000627 |
| mesh[32].descriptor_ui | D019386 |
| mesh[32].is_major_topic | True |
| mesh[32].qualifier_name | therapeutic use |
| mesh[32].descriptor_name | Alendronate |
| mesh[33].qualifier_ui | Q000008 |
| mesh[33].descriptor_ui | D000068296 |
| mesh[33].is_major_topic | True |
| mesh[33].qualifier_name | administration & dosage |
| mesh[33].descriptor_name | Risedronic Acid |
| mesh[34].qualifier_ui | Q000453 |
| mesh[34].descriptor_ui | D014739 |
| mesh[34].is_major_topic | False |
| mesh[34].qualifier_name | epidemiology |
| mesh[34].descriptor_name | Victoria |
| mesh[35].qualifier_ui | |
| mesh[35].descriptor_ui | D008875 |
| mesh[35].is_major_topic | False |
| mesh[35].qualifier_name | |
| mesh[35].descriptor_name | Middle Aged |
| mesh[36].qualifier_ui | |
| mesh[36].descriptor_ui | D000097042 |
| mesh[36].is_major_topic | False |
| mesh[36].qualifier_name | |
| mesh[36].descriptor_name | Treatment Interruption |
| mesh[37].qualifier_ui | |
| mesh[37].descriptor_ui | D000099059 |
| mesh[37].is_major_topic | False |
| mesh[37].qualifier_name | |
| mesh[37].descriptor_name | Assessment of Medication Adherence |
| mesh[38].qualifier_ui | |
| mesh[38].descriptor_ui | D006801 |
| mesh[38].is_major_topic | False |
| mesh[38].qualifier_name | |
| mesh[38].descriptor_name | Humans |
| mesh[39].qualifier_ui | Q000401 |
| mesh[39].descriptor_ui | D006620 |
| mesh[39].is_major_topic | True |
| mesh[39].qualifier_name | mortality |
| mesh[39].descriptor_name | Hip Fractures |
| mesh[40].qualifier_ui | |
| mesh[40].descriptor_ui | D005260 |
| mesh[40].is_major_topic | False |
| mesh[40].qualifier_name | |
| mesh[40].descriptor_name | Female |
| mesh[41].qualifier_ui | |
| mesh[41].descriptor_ui | D008297 |
| mesh[41].is_major_topic | False |
| mesh[41].qualifier_name | |
| mesh[41].descriptor_name | Male |
| mesh[42].qualifier_ui | |
| mesh[42].descriptor_ui | D012189 |
| mesh[42].is_major_topic | False |
| mesh[42].qualifier_name | |
| mesh[42].descriptor_name | Retrospective Studies |
| mesh[43].qualifier_ui | |
| mesh[43].descriptor_ui | D000368 |
| mesh[43].is_major_topic | False |
| mesh[43].qualifier_name | |
| mesh[43].descriptor_name | Aged |
| mesh[44].qualifier_ui | Q000008 |
| mesh[44].descriptor_ui | D050071 |
| mesh[44].is_major_topic | True |
| mesh[44].qualifier_name | administration & dosage |
| mesh[44].descriptor_name | Bone Density Conservation Agents |
| mesh[45].qualifier_ui | Q000627 |
| mesh[45].descriptor_ui | D050071 |
| mesh[45].is_major_topic | True |
| mesh[45].qualifier_name | therapeutic use |
| mesh[45].descriptor_name | Bone Density Conservation Agents |
| mesh[46].qualifier_ui | |
| mesh[46].descriptor_ui | D000369 |
| mesh[46].is_major_topic | False |
| mesh[46].qualifier_name | |
| mesh[46].descriptor_name | Aged, 80 and over |
| mesh[47].qualifier_ui | |
| mesh[47].descriptor_ui | D000284 |
| mesh[47].is_major_topic | False |
| mesh[47].qualifier_name | |
| mesh[47].descriptor_name | Administration, Oral |
| mesh[48].qualifier_ui | Q000008 |
| mesh[48].descriptor_ui | D004164 |
| mesh[48].is_major_topic | True |
| mesh[48].qualifier_name | administration & dosage |
| mesh[48].descriptor_name | Diphosphonates |
| mesh[49].qualifier_ui | Q000627 |
| mesh[49].descriptor_ui | D004164 |
| mesh[49].is_major_topic | True |
| mesh[49].qualifier_name | therapeutic use |
| mesh[49].descriptor_name | Diphosphonates |
| type | article |
| title | Effect of Oral Bisphosphonate Drug Holiday on Mortality Following Hip Fracture |
| biblio.issue | 11 |
| biblio.volume | 109 |
| biblio.last_page | 2801 |
| biblio.first_page | 2793 |
| topics[0].id | https://openalex.org/T11509 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9998000264167786 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2746 |
| topics[0].subfield.display_name | Surgery |
| topics[0].display_name | Hip and Femur Fractures |
| topics[1].id | https://openalex.org/T10071 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9993000030517578 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2732 |
| topics[1].subfield.display_name | Orthopedics and Sports Medicine |
| topics[1].display_name | Bone health and osteoporosis research |
| topics[2].id | https://openalex.org/T11221 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9983000159263611 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2730 |
| topics[2].subfield.display_name | Oncology |
| topics[2].display_name | Bone health and treatments |
| funders[0].id | https://openalex.org/F4320310738 |
| funders[0].ror | https://ror.org/027ahsj69 |
| funders[0].display_name | Dementia Australia Research Foundation |
| funders[1].id | https://openalex.org/F4320334705 |
| funders[1].ror | https://ror.org/011kf5r70 |
| funders[1].display_name | National Health and Medical Research Council |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C2778885795 |
| concepts[0].level | 3 |
| concepts[0].score | 0.7085947394371033 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q240856 |
| concepts[0].display_name | Hip fracture |
| concepts[1].id | https://openalex.org/C2777251235 |
| concepts[1].level | 3 |
| concepts[1].score | 0.7022001147270203 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q412205 |
| concepts[1].display_name | Bisphosphonate |
| concepts[2].id | https://openalex.org/C71924100 |
| concepts[2].level | 0 |
| concepts[2].score | 0.644000768661499 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[2].display_name | Medicine |
| concepts[3].id | https://openalex.org/C2780035454 |
| concepts[3].level | 2 |
| concepts[3].score | 0.6341732144355774 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q8386 |
| concepts[3].display_name | Drug |
| concepts[4].id | https://openalex.org/C199343813 |
| concepts[4].level | 1 |
| concepts[4].score | 0.43706125020980835 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q12128 |
| concepts[4].display_name | Dentistry |
| concepts[5].id | https://openalex.org/C126322002 |
| concepts[5].level | 1 |
| concepts[5].score | 0.3385528028011322 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[5].display_name | Internal medicine |
| concepts[6].id | https://openalex.org/C2776541429 |
| concepts[6].level | 2 |
| concepts[6].score | 0.24393939971923828 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q165328 |
| concepts[6].display_name | Osteoporosis |
| concepts[7].id | https://openalex.org/C98274493 |
| concepts[7].level | 1 |
| concepts[7].score | 0.18189215660095215 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q128406 |
| concepts[7].display_name | Pharmacology |
| keywords[0].id | https://openalex.org/keywords/hip-fracture |
| keywords[0].score | 0.7085947394371033 |
| keywords[0].display_name | Hip fracture |
| keywords[1].id | https://openalex.org/keywords/bisphosphonate |
| keywords[1].score | 0.7022001147270203 |
| keywords[1].display_name | Bisphosphonate |
| keywords[2].id | https://openalex.org/keywords/medicine |
| keywords[2].score | 0.644000768661499 |
| keywords[2].display_name | Medicine |
| keywords[3].id | https://openalex.org/keywords/drug |
| keywords[3].score | 0.6341732144355774 |
| keywords[3].display_name | Drug |
| keywords[4].id | https://openalex.org/keywords/dentistry |
| keywords[4].score | 0.43706125020980835 |
| keywords[4].display_name | Dentistry |
| keywords[5].id | https://openalex.org/keywords/internal-medicine |
| keywords[5].score | 0.3385528028011322 |
| keywords[5].display_name | Internal medicine |
| keywords[6].id | https://openalex.org/keywords/osteoporosis |
| keywords[6].score | 0.24393939971923828 |
| keywords[6].display_name | Osteoporosis |
| keywords[7].id | https://openalex.org/keywords/pharmacology |
| keywords[7].score | 0.18189215660095215 |
| keywords[7].display_name | Pharmacology |
| language | en |
| locations[0].id | doi:10.1210/clinem/dgae272 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S205775358 |
| locations[0].source.issn | 0021-972X, 1945-7197 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 0021-972X |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | The Journal of Clinical Endocrinology & Metabolism |
| locations[0].source.host_organization | https://openalex.org/P4310311648 |
| locations[0].source.host_organization_name | Oxford University Press |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310311648, https://openalex.org/P4310311647 |
| locations[0].source.host_organization_lineage_names | Oxford University Press, University of Oxford |
| locations[0].license | cc-by |
| locations[0].pdf_url | |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | The Journal of Clinical Endocrinology & Metabolism |
| locations[0].landing_page_url | https://doi.org/10.1210/clinem/dgae272 |
| locations[1].id | pmid:38630464 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | The Journal of clinical endocrinology and metabolism |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/38630464 |
| locations[2].id | pmh:oai:pubmedcentral.nih.gov:11479708 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S2764455111 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | PubMed Central |
| locations[2].source.host_organization | https://openalex.org/I1299303238 |
| locations[2].source.host_organization_name | National Institutes of Health |
| locations[2].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[2].license | other-oa |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Text |
| locations[2].license_id | https://openalex.org/licenses/other-oa |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | J Clin Endocrinol Metab |
| locations[2].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/11479708 |
| indexed_in | crossref, pubmed |
| authorships[0].author.id | https://openalex.org/A5052393035 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-4259-7058 |
| authorships[0].author.display_name | Miriam T Y Leung |
| authorships[0].countries | AU |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I56590836 |
| authorships[0].affiliations[0].raw_affiliation_string | Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University , Parkville, Melbourne, VIC 3052 , Australia |
| authorships[0].institutions[0].id | https://openalex.org/I56590836 |
| authorships[0].institutions[0].ror | https://ror.org/02bfwt286 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I56590836 |
| authorships[0].institutions[0].country_code | AU |
| authorships[0].institutions[0].display_name | Monash University |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Miriam T Y Leung |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University , Parkville, Melbourne, VIC 3052 , Australia |
| authorships[1].author.id | https://openalex.org/A5001007909 |
| authorships[1].author.orcid | https://orcid.org/0000-0003-0613-108X |
| authorships[1].author.display_name | Justin P. Turner |
| authorships[1].countries | AU, CA |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I56590836 |
| authorships[1].affiliations[0].raw_affiliation_string | Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University , Parkville, Melbourne, VIC 3052 , Australia |
| authorships[1].affiliations[1].institution_ids | https://openalex.org/I70931966 |
| authorships[1].affiliations[1].raw_affiliation_string | Faculty of Pharmacy, University of Montreal , Montreal, QC H3C 3J7 , Canada |
| authorships[1].affiliations[2].institution_ids | https://openalex.org/I4210126907 |
| authorships[1].affiliations[2].raw_affiliation_string | Centre de recherche, Institut Universitaire de gériatrie de Montréal , Montreal, QC H3W 1W5 , Canada |
| authorships[1].affiliations[3].institution_ids | https://openalex.org/I43406934 |
| authorships[1].affiliations[3].raw_affiliation_string | Faculty of Pharmacy, Laval University , Quebec City, QC G1V 0A6 , Canada |
| authorships[1].institutions[0].id | https://openalex.org/I56590836 |
| authorships[1].institutions[0].ror | https://ror.org/02bfwt286 |
| authorships[1].institutions[0].type | education |
| authorships[1].institutions[0].lineage | https://openalex.org/I56590836 |
| authorships[1].institutions[0].country_code | AU |
| authorships[1].institutions[0].display_name | Monash University |
| authorships[1].institutions[1].id | https://openalex.org/I4210126907 |
| authorships[1].institutions[1].ror | https://ror.org/031z68d90 |
| authorships[1].institutions[1].type | facility |
| authorships[1].institutions[1].lineage | https://openalex.org/I4210126907 |
| authorships[1].institutions[1].country_code | CA |
| authorships[1].institutions[1].display_name | Institut Universitaire de Gériatrie de Montréal |
| authorships[1].institutions[2].id | https://openalex.org/I43406934 |
| authorships[1].institutions[2].ror | https://ror.org/04sjchr03 |
| authorships[1].institutions[2].type | education |
| authorships[1].institutions[2].lineage | https://openalex.org/I43406934 |
| authorships[1].institutions[2].country_code | CA |
| authorships[1].institutions[2].display_name | Université Laval |
| authorships[1].institutions[3].id | https://openalex.org/I70931966 |
| authorships[1].institutions[3].ror | https://ror.org/0161xgx34 |
| authorships[1].institutions[3].type | education |
| authorships[1].institutions[3].lineage | https://openalex.org/I70931966 |
| authorships[1].institutions[3].country_code | CA |
| authorships[1].institutions[3].display_name | Université de Montréal |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Justin P Turner |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Centre de recherche, Institut Universitaire de gériatrie de Montréal , Montreal, QC H3W 1W5 , Canada, Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University , Parkville, Melbourne, VIC 3052 , Australia, Faculty of Pharmacy, Laval University , Quebec City, QC G1V 0A6 , Canada, Faculty of Pharmacy, University of Montreal , Montreal, QC H3C 3J7 , Canada |
| authorships[2].author.id | https://openalex.org/A5055201057 |
| authorships[2].author.orcid | https://orcid.org/0000-0003-2582-0374 |
| authorships[2].author.display_name | Clara Marquina |
| authorships[2].countries | AU |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I56590836 |
| authorships[2].affiliations[0].raw_affiliation_string | Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University , Parkville, Melbourne, VIC 3052 , Australia |
| authorships[2].institutions[0].id | https://openalex.org/I56590836 |
| authorships[2].institutions[0].ror | https://ror.org/02bfwt286 |
| authorships[2].institutions[0].type | education |
| authorships[2].institutions[0].lineage | https://openalex.org/I56590836 |
| authorships[2].institutions[0].country_code | AU |
| authorships[2].institutions[0].display_name | Monash University |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Clara Marquina |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University , Parkville, Melbourne, VIC 3052 , Australia |
| authorships[3].author.id | https://openalex.org/A5024051019 |
| authorships[3].author.orcid | https://orcid.org/0000-0002-0348-9441 |
| authorships[3].author.display_name | Jenni Ilomäki |
| authorships[3].countries | AU |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I56590836 |
| authorships[3].affiliations[0].raw_affiliation_string | Department of Epidemiology and Preventive Medicine, Monash University , Melbourne, VIC 3004 , Australia |
| authorships[3].affiliations[1].institution_ids | https://openalex.org/I56590836 |
| authorships[3].affiliations[1].raw_affiliation_string | Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University , Parkville, Melbourne, VIC 3052 , Australia |
| authorships[3].institutions[0].id | https://openalex.org/I56590836 |
| authorships[3].institutions[0].ror | https://ror.org/02bfwt286 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I56590836 |
| authorships[3].institutions[0].country_code | AU |
| authorships[3].institutions[0].display_name | Monash University |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Jenni Ilomaki |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University , Parkville, Melbourne, VIC 3052 , Australia, Department of Epidemiology and Preventive Medicine, Monash University , Melbourne, VIC 3004 , Australia |
| authorships[4].author.id | https://openalex.org/A5072032761 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-2924-3466 |
| authorships[4].author.display_name | Tim Tran |
| authorships[4].countries | AU |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I4210163497 |
| authorships[4].affiliations[0].raw_affiliation_string | Pharmacy Department, Austin Health , Heidelberg, Melbourne, VIC 3084 , Australia |
| authorships[4].institutions[0].id | https://openalex.org/I4210163497 |
| authorships[4].institutions[0].ror | https://ror.org/05dbj6g52 |
| authorships[4].institutions[0].type | healthcare |
| authorships[4].institutions[0].lineage | https://openalex.org/I4210163497 |
| authorships[4].institutions[0].country_code | AU |
| authorships[4].institutions[0].display_name | Austin Health |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Tim Tran |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Pharmacy Department, Austin Health , Heidelberg, Melbourne, VIC 3084 , Australia |
| authorships[5].author.id | https://openalex.org/A5063428081 |
| authorships[5].author.orcid | https://orcid.org/0000-0002-6115-2767 |
| authorships[5].author.display_name | J. Simon Bell |
| authorships[5].countries | AU, FI |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I175532246 |
| authorships[5].affiliations[0].raw_affiliation_string | Faculty of Health Sciences, University of Eastern Finland , Kuopio, FI-70211 , Finland |
| authorships[5].affiliations[1].institution_ids | https://openalex.org/I56590836 |
| authorships[5].affiliations[1].raw_affiliation_string | Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University , Parkville, Melbourne, VIC 3052 , Australia |
| authorships[5].affiliations[2].institution_ids | https://openalex.org/I56590836 |
| authorships[5].affiliations[2].raw_affiliation_string | Department of Epidemiology and Preventive Medicine, Monash University , Melbourne, VIC 3004 , Australia |
| authorships[5].institutions[0].id | https://openalex.org/I56590836 |
| authorships[5].institutions[0].ror | https://ror.org/02bfwt286 |
| authorships[5].institutions[0].type | education |
| authorships[5].institutions[0].lineage | https://openalex.org/I56590836 |
| authorships[5].institutions[0].country_code | AU |
| authorships[5].institutions[0].display_name | Monash University |
| authorships[5].institutions[1].id | https://openalex.org/I175532246 |
| authorships[5].institutions[1].ror | https://ror.org/00cyydd11 |
| authorships[5].institutions[1].type | education |
| authorships[5].institutions[1].lineage | https://openalex.org/I175532246 |
| authorships[5].institutions[1].country_code | FI |
| authorships[5].institutions[1].display_name | University of Eastern Finland |
| authorships[5].author_position | last |
| authorships[5].raw_author_name | J Simon Bell |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University , Parkville, Melbourne, VIC 3052 , Australia, Department of Epidemiology and Preventive Medicine, Monash University , Melbourne, VIC 3004 , Australia, Faculty of Health Sciences, University of Eastern Finland , Kuopio, FI-70211 , Finland |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.1210/clinem/dgae272 |
| open_access.oa_status | hybrid |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Effect of Oral Bisphosphonate Drug Holiday on Mortality Following Hip Fracture |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T11509 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9998000264167786 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2746 |
| primary_topic.subfield.display_name | Surgery |
| primary_topic.display_name | Hip and Femur Fractures |
| related_works | https://openalex.org/W2202140285, https://openalex.org/W2416738781, https://openalex.org/W2555482176, https://openalex.org/W2057037536, https://openalex.org/W2165796307, https://openalex.org/W1512264816, https://openalex.org/W1966504330, https://openalex.org/W1979139803, https://openalex.org/W1995319344, https://openalex.org/W2037631372 |
| cited_by_count | 6 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 3 |
| counts_by_year[1].year | 2024 |
| counts_by_year[1].cited_by_count | 3 |
| locations_count | 3 |
| best_oa_location.id | doi:10.1210/clinem/dgae272 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S205775358 |
| best_oa_location.source.issn | 0021-972X, 1945-7197 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | 0021-972X |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | The Journal of Clinical Endocrinology & Metabolism |
| best_oa_location.source.host_organization | https://openalex.org/P4310311648 |
| best_oa_location.source.host_organization_name | Oxford University Press |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310311648, https://openalex.org/P4310311647 |
| best_oa_location.source.host_organization_lineage_names | Oxford University Press, University of Oxford |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | The Journal of Clinical Endocrinology & Metabolism |
| best_oa_location.landing_page_url | https://doi.org/10.1210/clinem/dgae272 |
| primary_location.id | doi:10.1210/clinem/dgae272 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S205775358 |
| primary_location.source.issn | 0021-972X, 1945-7197 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 0021-972X |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | The Journal of Clinical Endocrinology & Metabolism |
| primary_location.source.host_organization | https://openalex.org/P4310311648 |
| primary_location.source.host_organization_name | Oxford University Press |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310311648, https://openalex.org/P4310311647 |
| primary_location.source.host_organization_lineage_names | Oxford University Press, University of Oxford |
| primary_location.license | cc-by |
| primary_location.pdf_url | |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | The Journal of Clinical Endocrinology & Metabolism |
| primary_location.landing_page_url | https://doi.org/10.1210/clinem/dgae272 |
| publication_date | 2024-04-17 |
| publication_year | 2024 |
| referenced_works | https://openalex.org/W2013724724, https://openalex.org/W3096212249, https://openalex.org/W1964891491, https://openalex.org/W1964069149, https://openalex.org/W4367369432, https://openalex.org/W4367393796, https://openalex.org/W3092298388, https://openalex.org/W4280554536, https://openalex.org/W2028195029, https://openalex.org/W1777836280, https://openalex.org/W4291123711, https://openalex.org/W4223481017, https://openalex.org/W4205808357, https://openalex.org/W3003305559, https://openalex.org/W3127350542, https://openalex.org/W2907009852, https://openalex.org/W2107494198, https://openalex.org/W3025411177, https://openalex.org/W2519827158, https://openalex.org/W3036784895, https://openalex.org/W4224237184, https://openalex.org/W3089977700, https://openalex.org/W2737733416, https://openalex.org/W1598612182, https://openalex.org/W3096484874, https://openalex.org/W2802067770, https://openalex.org/W2914585126, https://openalex.org/W2811157820, https://openalex.org/W2017267215, https://openalex.org/W2055213889, https://openalex.org/W3028962416, https://openalex.org/W2077170129, https://openalex.org/W3045527483, https://openalex.org/W4282841309, https://openalex.org/W3037592394, https://openalex.org/W3209854018, https://openalex.org/W3204356209, https://openalex.org/W2319932633, https://openalex.org/W2019797589, https://openalex.org/W2102385904, https://openalex.org/W4206528728, https://openalex.org/W4220876076, https://openalex.org/W4225283309 |
| referenced_works_count | 43 |
| abstract_inverted_index.1 | 149, 169, 206, 239 |
| abstract_inverted_index.2 | 156, 179, 214, 241 |
| abstract_inverted_index.5 | 84, 128, 251 |
| abstract_inverted_index.a | 6, 40, 259 |
| abstract_inverted_index.No | 190 |
| abstract_inverted_index.We | 113 |
| abstract_inverted_index.at | 249 |
| abstract_inverted_index.be | 258 |
| abstract_inverted_index.in | 46, 68, 162, 194, 199, 230 |
| abstract_inverted_index.is | 228 |
| abstract_inverted_index.no | 16 |
| abstract_inverted_index.of | 12, 22, 39, 51, 255 |
| abstract_inverted_index.on | 28, 43 |
| abstract_inverted_index.or | 81, 86, 130, 192, 213, 240 |
| abstract_inverted_index.to | 35, 73, 78, 89, 124, 136, 187, 222, 246, 261 |
| abstract_inverted_index.(HR | 181, 208, 216 |
| abstract_inverted_index.14% | 152 |
| abstract_inverted_index.17% | 145 |
| abstract_inverted_index.365 | 115 |
| abstract_inverted_index.95% | 175, 183, 210, 218 |
| abstract_inverted_index.CI, | 176, 184, 211, 219 |
| abstract_inverted_index.The | 105, 253 |
| abstract_inverted_index.all | 63 |
| abstract_inverted_index.and | 151, 178 |
| abstract_inverted_index.but | 235 |
| abstract_inverted_index.for | 83, 127, 142, 148, 155, 168, 205, 238, 248 |
| abstract_inverted_index.had | 146, 153, 165, 202 |
| abstract_inverted_index.hip | 26, 66, 90, 143, 188, 223 |
| abstract_inverted_index.may | 257 |
| abstract_inverted_index.not | 236 |
| abstract_inverted_index.the | 20, 37 |
| abstract_inverted_index.use | 11, 50, 137 |
| abstract_inverted_index.was | 109, 160, 197 |
| abstract_inverted_index.who | 164, 201, 232 |
| abstract_inverted_index.2014 | 72 |
| abstract_inverted_index.Most | 132 |
| abstract_inverted_index.This | 32, 55 |
| abstract_inverted_index.[HR] | 173 |
| abstract_inverted_index.drug | 7, 23, 41, 265 |
| abstract_inverted_index.from | 71 |
| abstract_inverted_index.good | 103, 118 |
| abstract_inverted_index.have | 18 |
| abstract_inverted_index.into | 97 |
| abstract_inverted_index.main | 106 |
| abstract_inverted_index.more | 87 |
| abstract_inverted_index.oral | 13, 52, 79, 125, 138 |
| abstract_inverted_index.took | 60 |
| abstract_inverted_index.type | 254 |
| abstract_inverted_index.were | 76 |
| abstract_inverted_index.when | 263 |
| abstract_inverted_index.with | 48, 65, 117 |
| abstract_inverted_index.work | 33 |
| abstract_inverted_index.year | 150, 170, 207 |
| abstract_inverted_index.(69%) | 134 |
| abstract_inverted_index.0.59; | 209 |
| abstract_inverted_index.1.05; | 217 |
| abstract_inverted_index.2.37; | 174 |
| abstract_inverted_index.2018. | 74 |
| abstract_inverted_index.3.08; | 182 |
| abstract_inverted_index.after | 9, 101, 243 |
| abstract_inverted_index.aimed | 34 |
| abstract_inverted_index.among | 62 |
| abstract_inverted_index.being | 244 |
| abstract_inverted_index.least | 250 |
| abstract_inverted_index.more. | 131 |
| abstract_inverted_index.place | 61 |
| abstract_inverted_index.prior | 88, 186, 221 |
| abstract_inverted_index.ratio | 122, 172 |
| abstract_inverted_index.study | 59 |
| abstract_inverted_index.until | 140 |
| abstract_inverted_index.usage | 100 |
| abstract_inverted_index.years | 85, 129, 180, 215, 242 |
| abstract_inverted_index.5-year | 102 |
| abstract_inverted_index.before | 25 |
| abstract_inverted_index.cohort | 58 |
| abstract_inverted_index.effect | 21, 38 |
| abstract_inverted_index.factor | 260 |
| abstract_inverted_index.higher | 161, 229 |
| abstract_inverted_index.people | 231 |
| abstract_inverted_index.years. | 157, 252 |
| abstract_inverted_index.(hazard | 171 |
| abstract_inverted_index.Context | 1 |
| abstract_inverted_index.Current | 2 |
| abstract_inverted_index.Methods | 54 |
| abstract_inverted_index.Results | 112 |
| abstract_inverted_index.holiday | 8, 42 |
| abstract_inverted_index.measure | 108 |
| abstract_inverted_index.outcome | 107 |
| abstract_inverted_index.studies | 17 |
| abstract_inverted_index.≥80%) | 123 |
| abstract_inverted_index.Abstract | 0 |
| abstract_inverted_index.However, | 15 |
| abstract_inverted_index.Patients | 75 |
| abstract_inverted_index.adherent | 77, 245 |
| abstract_inverted_index.clinical | 3 |
| abstract_inverted_index.consider | 262 |
| abstract_inverted_index.decrease | 193 |
| abstract_inverted_index.extended | 10, 49 |
| abstract_inverted_index.holidays | 24 |
| abstract_inverted_index.increase | 191 |
| abstract_inverted_index.modeling | 94 |
| abstract_inverted_index.observed | 198 |
| abstract_inverted_index.patients | 47, 64, 96, 116, 133, 163, 200 |
| abstract_inverted_index.planning | 264 |
| abstract_inverted_index.Objective | 31 |
| abstract_inverted_index.Victoria, | 69 |
| abstract_inverted_index.adherence | 119 |
| abstract_inverted_index.admission | 141 |
| abstract_inverted_index.continued | 135 |
| abstract_inverted_index.different | 98 |
| abstract_inverted_index.fracture. | 91, 189, 224 |
| abstract_inverted_index.fracture; | 144 |
| abstract_inverted_index.fractures | 27, 67 |
| abstract_inverted_index.holidays. | 266 |
| abstract_inverted_index.mortality | 45, 159, 196, 227 |
| abstract_inverted_index.recommend | 5 |
| abstract_inverted_index.treatment | 247 |
| abstract_inverted_index.0.29-1.18) | 212 |
| abstract_inverted_index.0.57-1.93) | 220 |
| abstract_inverted_index.1.24-4.53) | 177 |
| abstract_inverted_index.1.48-6.41) | 185 |
| abstract_inverted_index.Australia, | 70 |
| abstract_inverted_index.Conclusion | 225 |
| abstract_inverted_index.adherence. | 104 |
| abstract_inverted_index.guidelines | 4 |
| abstract_inverted_index.identified | 114 |
| abstract_inverted_index.mortality. | 30, 111 |
| abstract_inverted_index.possession | 121 |
| abstract_inverted_index.trajectory | 93 |
| abstract_inverted_index.(medication | 120 |
| abstract_inverted_index.Group-based | 92 |
| abstract_inverted_index.alendronate | 80, 204 |
| abstract_inverted_index.categorized | 95 |
| abstract_inverted_index.discontinue | 233 |
| abstract_inverted_index.investigate | 36 |
| abstract_inverted_index.risedronate | 82, 167 |
| abstract_inverted_index.Postfracture | 158, 226 |
| abstract_inverted_index.alendronate, | 237 |
| abstract_inverted_index.discontinued | 147, 154, 166, 203 |
| abstract_inverted_index.investigated | 19 |
| abstract_inverted_index.postfracture | 29, 44, 110, 195 |
| abstract_inverted_index.risedronate, | 234 |
| abstract_inverted_index.bisphosphonate | 99, 256 |
| abstract_inverted_index.retrospective, | 56 |
| abstract_inverted_index.bisphosphonates | 139 |
| abstract_inverted_index.bisphosphonates. | 14, 53 |
| abstract_inverted_index.population-based | 57 |
| abstract_inverted_index.alendronate/risedronate | 126 |
| cited_by_percentile_year.max | 97 |
| cited_by_percentile_year.min | 96 |
| countries_distinct_count | 3 |
| institutions_distinct_count | 6 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.8799999952316284 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.94601296 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | True |